Skip to content
Search

Latest Stories

Junior doctors accept government pay offer, ending NHS's longest industrial dispute

Junior doctors accept government pay offer, ending NHS's longest industrial dispute

Junior doctors’ strikes cost the taxpayer nearly £1.7 billion since April last year and led to over 1.5 million appointments cancelled

Junior doctors have accepted the government's pay offer by 66 per cent, marking the end of the most prolonged industrial dispute in the history of the NHS.

Following this new deal, a newly qualified doctor starting foundation training in the NHS will now receive a basic salary of £36,600, compared to around £32,400 prior to the agreement.


Beyond pay increases, the government and junior doctors agreed to work together to resolve wider issues affecting the workforce, including training and rotational placements.

Health and Social Care Secretary Wes Streeting made resolving the strikes his top priority, holding talks with the British Medical Association’s (BMA’s) junior doctors committee on his first day in office.

Streeting expressed his relief that the offer was agreed upon within weeks, ending the strikes ahead of looming winter pressures on the NHS.

He said: “We inherited a broken NHS, the most devastating dispute in the health service’s history, and negotiations hadn’t taken place with the previous ministers since March.

“Things should never have been allowed to get this bad. That’s why I made ending the strikes a priority, and we negotiated an end to them in just three weeks.

“This marks the necessary first step in our mission to cut waiting lists, reform the broken health service, and make it fit for the future.”

The deal comes just five days after Prime Minister Keir Starmer's major speech on NHS reform at the King’s Fund, where he outlined the government's commitment to fixing the health service with long-term reform.

He said that the NHS workforce will play an integral part in both designing and delivering the government’s 10-year health plan to deliver the necessary reform.

The pay dispute cost the taxpayer nearly £1.7 billion since April last year and led to over 1.5 million appointments cancelled, significantly impacting patient care.

In addition to resolving the pay dispute, the government has taken action to remove red tape preventing general practices from hiring doctors, ensuring the recruitment of over 1,000 newly qualified GPs by the end of the year.

The government also launched the Voluntary Scheme for Branded Medicine Pricing, Access, and Growth (VPAG) Investment Programme, a £400 million joint public-private initiative, last month, aimed at giving NHS patients faster access to new treatments and positioning the UK as a leader in cutting-edge health research.

Recognising the challenges posed by frequent job rotations for junior doctors and their families, the Department of Health and Social Care has decided to lead a review to reform the system, aiming to reduce the number and frequency of rotations.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less